TY - JOUR
T1 - Clinical and functional significance of intracellular and extracellular microRNA-25-3p in Osteosarcoma
AU - Yoshida, Aki
AU - Fujiwara, Tomohiro
AU - Uotani, Koji
AU - Morita, Takuya
AU - Kiyono, Masahiro
AU - Yokoo, Suguru
AU - Hasei, Jou
AU - Nakata, Eiji
AU - Kunisada, Toshiyuki
AU - Ozaki, Toshifumi
N1 - Funding Information:
We thank the member of the Central Research Laboratory of the Okayama University Medical School for the technical support for the isolation and validation of exosomes and histological analysis. The authors are supported by the Japan Orthopaedics and Traumatology Research Foundation (Grant no. 311), the Uehara Memorial Foundation, and JSPS KAKENHI Grants nos. 16K20054 and 16H05449.
Funding Information:
Acknowledgments. We thank the member of the Central Research Laboratory of the Okayama University Medical School for the technical support for the isolation and validation of exosomes and histological analysis. The authors are supported by the Japan Orthopaedics and Traumatology Research Foundation (Grant no. 311), the Uehara Memorial Foundation, and JSPS KAKENHI Grants nos. 16K20054 and 16H05449.
Publisher Copyright:
© 2018 by Okayama University Medical School.
PY - 2018
Y1 - 2018
N2 - Although there is considerable evidence indicating that the dysregulation of microRNAs (miRNAs) in malignant tumors plays a role in tumor development, the overall function of miRNAs and their clinicopathological significance are not well understood. In this retrospective analysis of 45 biopsy specimens from osteosarcoma (OS) patients, we investigated the functional and clinical significance of miR-25-3p in OS, which we previously identified as a highly expressed miRNA in OS patients' serum. We observed that miR-25-3p dysregulation in human OS tissues was negatively correlated with the clinical prognosis, whereas the expression level of its target gene, Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3), was positively correlated with the clinical prognosis. Endogenous miR-25-3p upregulation promoted tumor growth, invasion, and drug resistance, which was consistent with DKK3 silencing in OS cells. In addition, secretory miR-25-3p was embedded in tumor-derived exosomes, where it promoted capillary formation and the invasion of vascular endothelial cells. Overall, our results show that miR-25-3p has intracellular and extracellular oncogenic functions as well as clinicopathological relevance in OS, indicating its potential as a novel diagnostic and therapeutic tool for the clinical management of this disease.
AB - Although there is considerable evidence indicating that the dysregulation of microRNAs (miRNAs) in malignant tumors plays a role in tumor development, the overall function of miRNAs and their clinicopathological significance are not well understood. In this retrospective analysis of 45 biopsy specimens from osteosarcoma (OS) patients, we investigated the functional and clinical significance of miR-25-3p in OS, which we previously identified as a highly expressed miRNA in OS patients' serum. We observed that miR-25-3p dysregulation in human OS tissues was negatively correlated with the clinical prognosis, whereas the expression level of its target gene, Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3), was positively correlated with the clinical prognosis. Endogenous miR-25-3p upregulation promoted tumor growth, invasion, and drug resistance, which was consistent with DKK3 silencing in OS cells. In addition, secretory miR-25-3p was embedded in tumor-derived exosomes, where it promoted capillary formation and the invasion of vascular endothelial cells. Overall, our results show that miR-25-3p has intracellular and extracellular oncogenic functions as well as clinicopathological relevance in OS, indicating its potential as a novel diagnostic and therapeutic tool for the clinical management of this disease.
KW - Circulating microRNA
KW - Osteosarcoma
KW - Prognosis
KW - microRNA
UR - http://www.scopus.com/inward/record.url?scp=85047196558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047196558&partnerID=8YFLogxK
M3 - Article
C2 - 29674765
AN - SCOPUS:85047196558
SN - 0386-300X
VL - 72
SP - 165
EP - 174
JO - Acta Medica Okayama
JF - Acta Medica Okayama
IS - 2
ER -